These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 26922873)

  • 41. Insights into amylin-leptin synergy.
    Trevaskis JL; Parkes DG; Roth JD
    Trends Endocrinol Metab; 2010 Aug; 21(8):473-9. PubMed ID: 20413324
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Central amylin signaling and the regulation of energy homeostasis.
    Rushing PA
    Curr Pharm Des; 2003; 9(10):819-25. PubMed ID: 12678881
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mediators of Amylin Action in Metabolic Control.
    Boyle CN; Zheng Y; Lutz TA
    J Clin Med; 2022 Apr; 11(8):. PubMed ID: 35456307
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Central control of energy balance by amylin and calcitonin receptor agonists and their potential for treatment of metabolic diseases.
    Zakariassen HL; John LM; Lutz TA
    Basic Clin Pharmacol Toxicol; 2020 Sep; 127(3):163-177. PubMed ID: 32363722
    [TBL] [Abstract][Full Text] [Related]  

  • 45. THERAPY OF ENDOCRINE DISEASE: Amylin and calcitonin - physiology and pharmacology.
    Mathiesen DS; Lund A; Holst JJ; Knop FK; Lutz TA; Bagger JI
    Eur J Endocrinol; 2022 Apr; 186(6):R93-R111. PubMed ID: 35353712
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Amylinergic control of food intake.
    Lutz TA
    Physiol Behav; 2006 Nov; 89(4):465-71. PubMed ID: 16697020
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibition of glucagon secretion.
    Young A
    Adv Pharmacol; 2005; 52():151-71. PubMed ID: 16492545
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Novel peptides under development for the treatment of type 1 and type 2 diabetes mellitus.
    Baron AD; Kim D; Weyer C
    Curr Drug Targets Immune Endocr Metabol Disord; 2002 Apr; 2(1):63-82. PubMed ID: 12477297
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pramlintide: profile of an amylin analog.
    Lebovitz HE
    Expert Rev Endocrinol Metab; 2012 Nov; 7(6):599-609. PubMed ID: 30754127
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interactions of amylinergic and melanocortinergic systems in the control of food intake and body weight in rodents.
    Roth JD; D'Souza L; Griffin PS; Athanacio J; Trevaskis JL; Nazarbaghi R; Jodka C; Athanacio J; Hoyt J; Forood B; Parkes DG
    Diabetes Obes Metab; 2012 Jul; 14(7):608-15. PubMed ID: 22276636
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interaction of leptin and amylin in the long-term maintenance of weight loss in diet-induced obese rats.
    Trevaskis JL; Lei C; Koda JE; Weyer C; Parkes DG; Roth JD
    Obesity (Silver Spring); 2010 Jan; 18(1):21-6. PubMed ID: 19543217
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Amylin and Calcitonin: Potential Therapeutic Strategies to Reduce Body Weight and Liver Fat.
    Mathiesen DS; Lund A; Vilsbøll T; Knop FK; Bagger JI
    Front Endocrinol (Lausanne); 2020; 11():617400. PubMed ID: 33488526
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Creating the amylin story.
    Lutz TA
    Appetite; 2022 May; 172():105965. PubMed ID: 35183619
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Amylin-mediated restoration of leptin responsiveness in diet-induced obesity: magnitude and mechanisms.
    Trevaskis JL; Coffey T; Cole R; Lei C; Wittmer C; Walsh B; Weyer C; Koda J; Baron AD; Parkes DG; Roth JD
    Endocrinology; 2008 Nov; 149(11):5679-87. PubMed ID: 18669592
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Monoconjugation of Human Amylin with Methylpolyethyleneglycol.
    Sisnande T; Guerreiro LH; Braga RR; Jotha-Mattos L; Erthal LC; Tinoco P; Ferreira BM; Lima LM
    PLoS One; 2015; 10(10):e0138803. PubMed ID: 26448437
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Type-2 Diabetes, Pancreatic Amylin, and Neuronal Metabolic Remodeling in Alzheimer's Disease.
    Leibold N; Bain JR; Despa F
    Mol Nutr Food Res; 2024 Jul; 68(13):e2200405. PubMed ID: 36708219
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Anorectic effects of amylin in rats over the life span.
    Morley JE; Morley PM; Flood JF
    Pharmacol Biochem Behav; 1993 Mar; 44(3):577-80. PubMed ID: 8451261
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The therapeutic potential of metabolic hormones in the treatment of age-related cognitive decline and Alzheimer's disease.
    Grizzanti J; Lee HG; Camins A; Pallas M; Casadesus G
    Nutr Res; 2016 Dec; 36(12):1305-1315. PubMed ID: 27923524
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pramlintide in the treatment of type 1 and type 2 diabetes mellitus.
    Ryan GJ; Jobe LJ; Martin R
    Clin Ther; 2005 Oct; 27(10):1500-12. PubMed ID: 16330288
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The role of leptin in the sporadic form of Alzheimer's disease. Interactions with the adipokines amylin, ghrelin and the pituitary hormone prolactin.
    Folch J; Patraca I; Martínez N; Pedrós I; Petrov D; Ettcheto M; Abad S; Marin M; Beas-Zarate C; Camins A
    Life Sci; 2015 Nov; 140():19-28. PubMed ID: 25998028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.